Prophylactic Tranexamic Acid Prevents Postpartum Hemorrhage and Transfusions in Cesarean Deliveries: A Systematic Review and Meta-analysis

被引:1
|
作者
Lee, Amy [1 ,3 ]
Wang, Mary Ying-Fang [1 ]
Roy, Debosree [1 ]
Wang, Jenny [1 ]
Gokhale, Abha [1 ]
Miranda-Cacdac, Lauren [1 ]
Kuntz, Moriah [1 ]
Grover, Bryan [2 ]
Gray, Kendra [2 ]
Curley, Kathleen L. [2 ]
机构
[1] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA
[2] Banner Univ, Dept Obstet & Gynecol, Med Ctr Phoenix, Phoenix, AZ USA
[3] Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03766, Lebanon
关键词
tranexamic acid; TXA; postpartum hemorrhage; cesarean; transfusion; prophylactic; BLOOD-LOSS; DOUBLE-BLIND; SECTION;
D O I
10.1055/a-2109-3730
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide and PPH resulting in transfusion is themost common maternalmorbidity in the United States. Literature demonstrates that tranexamic acid (TXA) can reduce blood loss in cesarean deliveries; however, there is little consensus on the impact on major morbidities like PPH and transfusions. We conducted a systematic review/meta-analysis of randomized controlled trials (RCTs) to evaluate if administration of prophylactic intravenous (IV) TXA prevents PPH and/or transfusions following low-risk cesarean delivery. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines were followed. Five databases were searched: Cochrane, EBSCO, Ovid, PubMed, and ClinicalKey. RCTs published in English between January 2000 and December 2021 were included. Studies compared PPH and transfusions in cesarean deliveries between prophylactic IV TXA and control (placebo or no placebo). The primary outcome was PPH, and the secondary outcome was transfusions. Random effects models were used to calculate effect size (ES) of exposure in Mantel-Haenszel risk ratios (RR). All analysis was done at a confidence level (CI) of alpha = 0.5. Modeling showed that TXA led to significantly less risk of PPH than control (RR: 0.43; 95% CI: 0.28-0.67). The effect on transfusion was comparable (RR: 0.39; 95% CI: 0.21-0.73). Heterogeneity was minimal (I-2 = 0%). Due to the large sample sizes needed, many RCTs are not powered to interpret TXA's effect on PPH and transfusions. Pooling these studies in a meta-analysis allows for more power and analysis but is limited by the heterogeneity of studies. Our results minimize heterogeneity while demonstrating that prophylactic TXA can lower PPH occurrence and reduce the need for blood transfusion. We suggest considering prophylactic IV TXA as the standard of care in low-risk cesarean deliveries.
引用
收藏
页码:e2254 / e2268
页数:15
相关论文
共 50 条
  • [21] Efficacy of high dose tranexamic acid (TXA) for hemorrhage: A systematic review and meta-analysis
    Simsam, Mohammad Hmidan
    Delorme, Laurence
    Grimm, Dylan
    Priestap, Fran
    Bohnert, Sara
    Descoteaux, Marc
    Hilsden, Rich
    Laverty, Colin
    Mickler, John
    Parry, Neil
    Rochwerg, Bram
    Sherman, Christopher
    Smith, Shane
    Toole, Jason
    Vogt, Kelly
    Wilson, Sean
    Ball, Ian
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2023, 54 (03): : 857 - 870
  • [22] Tranexamic Acid for Adult Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review with Meta-analysis
    Wang, Xing
    Ma, Lu
    Song, Jinlei
    You, Chao
    CNS DRUGS, 2021, 35 (11) : 1163 - 1172
  • [23] Tranexamic Acid for Adult Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review with Meta-analysis
    Xing Wang
    Lu Ma
    Jinlei Song
    Chao You
    CNS Drugs, 2021, 35 : 1163 - 1172
  • [24] Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials
    Della Corte, Luigi
    Saccone, Gabriele
    Locci, Mariavittoria
    Carbone, Luigi
    Raffone, Antonio
    Giampaolino, Pierluigi
    Ciardulli, Andrea
    Berghella, Vincenzo
    Zullo, Fulvio
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (05): : 869 - 874
  • [25] Prophylactic Topical Tranexamic Acid versus Placebo in Surgical Patients: A Systematic Review and Meta-Analysis
    Teoh, W. Y.
    Tan, T. G.
    Ng, K. T.
    Ong, K. X.
    Chan, X. L.
    Tsan, S. E. Hung
    Wang, C. Y.
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 6 - 6
  • [26] Prophylactic Topical Tranexamic Acid Versus Placebo in Surgical Patients A Systematic Review and Meta-analysis*
    Teoh, Wan Yi
    Tan, Tun Giap
    Ng, Ka Ting
    Ong, Ke Xin
    Chan, Xue Lin
    Hung Tsan, Samuel Ern
    Wang, Chew Yin
    ANNALS OF SURGERY, 2021, 273 (04) : 676 - 683
  • [27] Prophylactic tranexamic acid during myomectomy: A systematic review and meta-analysis of randomized controlled trials
    Baradwan, Saeed
    Hafidh, Bandr
    Latifah, Hassan M.
    Gari, Abdulrahim
    Sabban, Hussein
    Abduljabbar, Hanin Hassan
    Tawfiq, Afaf
    Hakeem, Ghaidaa Farouk
    Alkaff, Alya
    AlSghan, Rayan
    Alshahrani, Majed Saeed
    Badghish, Ehab
    Abu-Zaid, Ahmed
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 276 : 82 - 91
  • [28] Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveries
    Voon, Hian Yan
    Suharjono, Haris Njoo
    Shafie, Asrul Akmal
    Bujang, Mohamad Adam
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (03): : 332 - 339
  • [29] The Effectiveness and Safety of Tranexamic Acid in Treating Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
    Al Zayer, Mohammed O.
    Al Johani, Fatima M.
    Al Ghamdi, Shahad A.
    Al Hejaili, Mohammed D.
    Al Mukhtar, Fatima H.
    Al Ariany, Arwa M.
    Al Anazi, Bashar H.
    Al Mutairi, Khalid A.
    Khoja, Rammaz H.
    Al Amer, Haidar F.
    Zeidan, Adel A.
    Al Faraj, Dunya
    HEALTHCARE, 2024, 12 (23)
  • [30] Quality of life after vaginal and cesarean deliveries: a systematic review and meta-analysis
    Rezaei, Satar
    Salimi, Yahya
    Moghadam, Telma Zahirian
    Mirzarahimi, Tiba
    Mehrtak, Mohammad
    Zandian, Hamed
    INTERNATIONAL JOURNAL OF HUMAN RIGHTS IN HEALTH CARE, 2018, 11 (03) : 165 - 175